Our therapy areas

Phenylketonuria (PKU)

Phenylketonuria (PKU) is a rare inherited metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase (PAH).1

Signs and symptoms of Phenylketonuria (PKU)

Phenylketonuria (PKU) is caused by deficiency of phenylalanine hydroxylase (PAH).1 This enzyme is required for the breakdown of phenylalanine (Phe), an essential amino acid found in all protein-containing foods.1,2 When PAH is deficient or defective, Phe accumulates to abnormally high levels in the blood and brain.2,3

Clinical manifestations of sustained high Phe levels include a variety of serious neurological and neuropsychological complications, including:3-6

  • Mood disturbances
  • Tremors
  • Cognitive problems
  • Executive function deficits

References:

  1. van Spronsen FJ et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol 2017;5(9):743-56.
  2. Blau N et al. Phenylketonuria. Lancet 2010;376(9750):1417-27.
  3. Enns GM et al. Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence. Mol Genet Metab 2010;101:99-109.
  4. Bilder DA et al. Systematic review and meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria. Dev Neuropsychol 2016;41(4):245-60.
  5. Jahja R et al. Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study. Neuropsychology 2017;31(4):437-47.
  6. Clacy A et al. Depression, anxiety, and stress in young adults with phenylketonuria: Associations with biochemistry. J Dev Behav Pediatr 2014;35(6):388-91.

Our therapy areas

A girl dancing happily

Achondroplasia

Achondroplasia is a rare genetic bone growth disorder and the most common form of disproportionate short stature. It is caused by a change in the fibroblast growth factor receptor 3 (FGFR3) gene, which impairs the growth of bone in the cartilage of the growth plate.

Read more

Image of a happy CLN2 patient

Late infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease

Late infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease is an ultra-rare and rapidly progressive paediatric brain disorder and one of the most common forms of neuronal ceroid lipofuscinosis, a group of inherited disorders collectively known as Batten disease.

Read more

Image of a happy MPS VI patient

Mucopolysaccharidosis VI (MPS VI)

Mucopolysaccharidosis VI (MPS VI), also known as Maroteaux-Lamy Syndrome, is an ultra-rare inherited lysosomal storage disorder caused by the deficiency of N-acetylgalactosamine-4-sulfatase (arylsulfatase B), an enzyme required for the breakdown of certain complex carbohydrates known as glycosaminoglycans (GAGs).

Read more

Image of a happy MPS IVA patient

Mucopolysaccharidosis type IVA

Mucopolysaccharidosis type IVA (MPS IVA), also known as Morquio A syndrome, is an ultra-rare inherited lysosomal storage disorder caused by the deficiency of N-acetylgalactosamine-6-sulfatase (GALNS), an enzyme required for the breakdown of certain complex carbohydrates known as glycosaminoglycans (GAGs).

Read more